• Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Lansen Pharmaceutical Holdings Ltd

+ Add to Watchlist

503:HK

3.780 HKD 0.070 1.82%

As of 04:01:04 ET on 09/30/2014.

Snapshot for Lansen Pharmaceutical Holdings Ltd (503)

Open: 3.700 Day's Range: 3.630 - 3.840 Volume: 1,299,000
Previous Close: 3.850 52wk Range: 2.470 - 4.150 1-Yr Rtn: +55.06%

Stock Chart for 503

No chart data available.
  • 503:HK 3.780
  • 1D
  • 1M
  • 1Y
3.850
Interactive 503 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 503

Current P/E Ratio (ttm) 15.7044
Estimated P/E(12/2014) -
Relative P/E vs. HSI 1.5732
Earnings Per Share (USD) (ttm) 0.0310
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M HKD) 1,568.70
Shares Outstanding (M) 415.00
30 Day Average Volume 1,196,833
Price/Book (mrq) 1.8257
Price/Sale (ttm) 1.9417
Dividend Indicated Gross Yield 4.36%
Cash Dividend (HKD) 0.0954
Dividend Ex-Date 09/30/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 503

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 503

Lansen Pharmaceutical holdings Ltd. is a pharmaceutical holding company. The Company's subsidiaries produce and sell rheumatic specialty prescription western pharmaceuticals in the Peoples Republic of China.

Liu Ming-BangChief Executive OfficerMui Chi HungCFO/Secretary
Poon Lei YungSenior Vice PresidentZhou RongSenior Vice President
More Company Profile & Key Executives for 503

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil